Cosmos Signs Five-Year Manufacturing Deal with Pharmex for 2.6 Million Units

Cosmos has signed a five-year manufacturing agreement with Pharmex for 2.6 million units, effective June 17, 2026. This deal secures a significant production commitment for Cosmos, signaling potential revenue stability and increased operational capacity. The agreement specifies the production of 2.6 million units over the five-year term. Financial terms of the deal and the specific types of products to be manufactured were not immediately disclosed by either company.